Medicus Pharma MDCXW
NASDAQ MDCXW
$0.33 -0.11 (-24.95%)
At close: Aug 11, 2026 · 4:00 PM EDT

Medicus Pharma Ltd. (MDCXW) Research & Development (2024 - 2026)

Medicus Pharma's (MDCXW) quarterly Research & Development came in at -$996039.0 in Q4 2025, down 111.43% on a QoQ basis from $8.7 million in Q3 2025.

Medicus Pharma Ltd. (MDCXW) Research & Development (2024 - 2026) Analysis & Trends

Medicus Pharma (MDCXW) has 2 years of Research & Development data on file, last reported at -$996039.0 in Q4 2025.

  • Quarterly Research & Development changed N/A year-over-year to -$996039.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (up 598.59% YoY) and the FY2025 annual result came in at $7.7 million, changed N/A from the prior year.
  • Research & Development slipped to -$996039.0 in Q4 2025, from $8.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $8.7 million in Q3 2025 to a low of -$996039.0 in Q4 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 4.91 Mn
Dec 31, 2025 -996,039.00
Sep 30, 2025 8.72 Mn
Jun 30, 2025 1.44 Mn
Mar 31, 2025 2.01 Mn
Jun 30, 2024 1.28 Mn
Mar 31, 2024 321,377.00